Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

HEALTH, VIRGINIA DEPARTMENT OF Richmond VA 23219-1438 USA

UEI: SLED_4A85E816B936EE11

HEALTH, VIRGINIA DEPARTMENT OF Richmond VA 23219-1438 USA is a federal contractor, registered under UEI SLED_4A85E816B936EE11. It has been awarded $1,220,434 in federal contracts. Primary work spans Blood and Organ Banks. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_4A85E816B936EE11

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

The Virginia Department of Health provides specialized forensic and medical examiner services. Their core capabilities include the operation of the Office of the Chief Medical Examiner, with technical expertise in forensic pathology and death investigation across multiple districts. The contractor ...

The Virginia Department of Health provides specialized forensic and medical examiner services. Their core capabilities include the operation of the Office of the Chief Medical Examiner, with technical expertise in forensic pathology and death investigation across multiple districts. The contractor has experience working with the Department of Health and Human Services, delivering specialized medical examiner services through firm fixed price arrangements. Their industry focus is centered on NAICS 621991, specializing in forensic medical services and government-mandated death investigations. The organization maintains a geographic presence in Richmond, Virginia, with operational facilities serving the Central and Northern districts.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with HEALTH, VIRGINIA DEPARTMENT OF Richmond VA 23219-1438 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for HEALTH, VIRGINIA DEPARTMENT OF Richmond VA 23219-1438 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in HEALTH, VIRGINIA DEPARTMENT OF Richmond VA 23219-1438 USA's top NAICS codes and agencies

NAICS: 325411
New
Federal
Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics
Solicitation # 75N98027R00020
The National Center for Advancing Translational Sciences within the National Institutes of Health has issued a Sources Sought notice for an IDIQ contract focused on reagent generation for bioanalytical method development on biologics therapeutics. The primary objective is to identify qualified sources capable of generating and delivering high-affinity, specific anti-drug antibodies, including neutralizing antibodies and antibodies against carriers or gene-of-interest protein products. These reagents will support the quantification of novel biologic drugs in biological matrices such as plasma, serum, and tissue homogenates. The anticipated scope includes the production of polyclonal and monoclonal antibodies, specificity characterization, and the delivery of purified antibodies at an estimated scale of 10 to 50 mg per reagent. The required performance standards are rigorous, demanding adherence to US FDA current Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice, as well as ICH and ISO regulations. Contractors must maintain a comprehensive Quality Management Plan and an independent Quality Assurance Unit to ensure all products meet strict quality requirements. Additional requirements include the development of standard operating procedures for packaging and shipping, the maintenance of secure facilities with restricted access, and the implementation of contingency plans for catastrophic events. The anticipated period of performance for this effort is ten years. Interested respondents must be registered in the System for Award Management and provide a capability statement under NAICS code 325411 by November 30, 2026.
National Institutes Of Health Nida

POSTED

1 day ago

DEADLINE

in 13 days
View Details
NAICS: 541715
Federal
Synthesis and Distribution of Drugs of Abuse and Related Compounds
Solicitation # 75N98027R00006OT
The National Institute on Drug Abuse (NIDA) is issuing a Sources Sought Notice to identify qualified business organizations capable of supporting the synthesis and distribution of drugs of abuse and related compounds. This is not a solicitation for proposals, but a market research effort to determine the availability of technically capable commercial or non-commercial sources and to identify the appropriate acquisition method. The scope of work involves producing, acquiring, and maintaining an inventory of labeled and unlabeled chemical substances, ensuring purity levels of at least 95 percent, and managing the secure storage and shipment of these compounds to research investigators. Interested vendors must demonstrate the ability to handle large quantities of DEA controlled and uncontrolled substances, including peptides, narcotics, and stimulants, some of which require refrigeration. A mandatory requirement for any capable vendor is the possession of a DEA Research Registration for Schedules II through V and the ability to obtain registration for Schedule I substances. Organizations must submit a capability statement of no more than ten pages, including their UEI number, business size, and detailed evidence of staff expertise and prior experience, to the designated Contract Specialist by November 20, 2026.
National Institutes Of Health Nida

POSTED

20 days ago

DEADLINE

in 3 days
View Details
NAICS: 541715
Federal
Synthesis and Distribution of Drugs of Abuse and Related Compounds
Solicitation # 75N98027R00006SB
The National Institute on Drug Abuse (NIDA) is issuing a Small Business Sources Sought Notice to identify qualified small business organizations capable of supporting the synthesis and distribution of drugs of abuse and related compounds. This is a market research effort to determine the availability of technically capable sources and to decide if a small business set-aside is appropriate under NAICS code 541715. The scope of work includes producing, acquiring, and maintaining an inventory of labeled and unlabeled chemical substances, testing for purity, managing the Drug Inventory Supply Control System (DISCS), and ensuring the secure storage and shipment of compounds to research investigators. Interested vendors must demonstrate the ability to store large quantities of DEA-controlled and uncontrolled substances, including peptides, while maintaining a purity level of at least 95 percent. A mandatory requirement for this effort is that vendors possess a DEA Research Registration for Schedules II through V and show the capability to obtain registration for Schedule I substances. Qualified small businesses must submit a capability statement, limited to ten pages, to the designated contract specialist by November 20, 2026. This notice is for information purposes only and does not constitute a solicitation or a commitment to award a contract.
National Institutes Of Health Nida

POSTED

20 days ago

DEADLINE

in 3 days
View Details
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.
National Institutes Of Health

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details
NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

4 months ago

DEADLINE

in 8 months
View Details